Literature DB >> 32922009

Efficacy and Molecular Effects of a Reduced Graphene Oxide/Fe3O4 Nanocomposite in Photothermal Therapy Against Cancer.

Claudia C Barrera1, Helena Groot1, Watson L Vargas2, Diana M Narváez1.   

Abstract

PURPOSE: Expanded research on the biomedical applications of graphene has shown promising results, although interactions between cells and graphene are still unclear. The current study aims to dissect the cellular and molecular effects of graphene nanocomposite in photothermal therapy against cancer, and to evaluate its efficacy.
METHODS: In this study, a reduced graphene oxide and iron oxide (rGO-Fe3O4) nanocomposite was obtained by chemical synthesis. The nanocomposite was fully characterized by Raman spectroscopy, TEM, VSM and thermal profiling. Cell-nanocomposite interaction was evaluated by confocal microscopy and viability assays on cancer cell line HeLa. The efficacy of the thermal therapy and changes in gene expression of Bcl-2 and Hsp70 was assessed.
RESULTS: The resulting rGO-Fe3O4 nanocomposite exhibited superparamagnetic properties and the capacity to increase the surrounding temperature by 18-20°C with respect to the initial temperature. The studies of cell-nanocomposite interaction showed that rGO-Fe3O4 attaches to cell membrane but there is a range of concentration at which the nanomaterial preserves cell viability. Photothermal therapy reduced cell viability to 32.6% and 23.7% with 50 and 100 µg/mL of nanomaterial, respectively. The effect of treatment on the molecular mechanism of cell death demonstrated an overexpression of anti-apoptotic proteins Hsp70 and Bcl-2 as an initial response to the therapy and depending on the aggressiveness of the treatment.
CONCLUSION: The results of this study contribute to understanding the interactions between cell and graphene and support its application in photothermal therapy against cancer due to its promising results.
© 2020 Barrera et al.

Entities:  

Keywords:  anti-apoptotic genes; cell viability; iron oxide; molecular effect; photothermal therapy; reduced graphene oxide

Mesh:

Substances:

Year:  2020        PMID: 32922009      PMCID: PMC7457756          DOI: 10.2147/IJN.S256760

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  41 in total

1.  PEGylated lipid bilayer-wrapped nano-graphene oxides for synergistic co-delivery of doxorubicin and rapamycin to prevent drug resistance in cancers.

Authors:  Raj Kumar Thapa; Jeong Hoon Byeon; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Nanotechnology       Date:  2017-06-14       Impact factor: 3.874

2.  Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms.

Authors:  Marta Pérez-Hernández; Pablo Del Pino; Scott G Mitchell; María Moros; Grazyna Stepien; Beatriz Pelaz; Wolfgang J Parak; Eva M Gálvez; Julián Pardo; Jesús M de la Fuente
Journal:  ACS Nano       Date:  2014-12-17       Impact factor: 15.881

3.  Graphene-based nanocomposite as an effective, multifunctional, and recyclable antibacterial agent.

Authors:  Tengfei Tian; Xiaoze Shi; Liang Cheng; Yinchan Luo; Ziliang Dong; Hua Gong; Ligeng Xu; Zengtao Zhong; Rui Peng; Zhuang Liu
Journal:  ACS Appl Mater Interfaces       Date:  2014-05-15       Impact factor: 9.229

4.  Biocompatibility of microbially reduced graphene oxide in primary mouse embryonic fibroblast cells.

Authors:  Sangiliyandi Gurunathan; Jae Woong Han; Vasuki Eppakayala; Jin-Hoi Kim
Journal:  Colloids Surf B Biointerfaces       Date:  2013-01-05       Impact factor: 5.268

5.  Scalable production of large quantities of defect-free few-layer graphene by shear exfoliation in liquids.

Authors:  Keith R Paton; Eswaraiah Varrla; Claudia Backes; Ronan J Smith; Umar Khan; Arlene O'Neill; Conor Boland; Mustafa Lotya; Oana M Istrate; Paul King; Tom Higgins; Sebastian Barwich; Peter May; Pawel Puczkarski; Iftikhar Ahmed; Matthias Moebius; Henrik Pettersson; Edmund Long; João Coelho; Sean E O'Brien; Eva K McGuire; Beatriz Mendoza Sanchez; Georg S Duesberg; Niall McEvoy; Timothy J Pennycook; Clive Downing; Alison Crossley; Valeria Nicolosi; Jonathan N Coleman
Journal:  Nat Mater       Date:  2014-04-20       Impact factor: 43.841

6.  Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy.

Authors:  Xiaoze Shi; Hua Gong; Yingjie Li; Chao Wang; Liang Cheng; Zhuang Liu
Journal:  Biomaterials       Date:  2013-04-01       Impact factor: 12.479

7.  IR-enhanced photothermal therapeutic effect of graphene magnetite nanocomposite on human liver cancer HepG2 cell model.

Authors:  Taher A Salaheldin; Samah A Loutfy; Marwa A Ramadan; Tareq Youssef; Shaker A Mousa
Journal:  Int J Nanomedicine       Date:  2019-06-17

Review 8.  Assessment of the toxic potential of graphene family nanomaterials.

Authors:  Xiaoqing Guo; Nan Mei
Journal:  J Food Drug Anal       Date:  2014-02-04       Impact factor: 6.079

9.  Biocompatible synthesis of reduced graphene oxide from Euphorbia heterophylla (L.) and their in-vitro cytotoxicity against human cancer cell lines.

Authors:  K Lingaraju; H Raja Naika; G Nagaraju; H Nagabhushana
Journal:  Biotechnol Rep (Amst)       Date:  2019-09-12

Review 10.  Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers.

Authors:  Sumit Arora
Journal:  Int J Nanomedicine       Date:  2012-07-06
View more
  2 in total

1.  The effects of the oral administration of graphene oxide on the gut microbiota and ultrastructure of the colon of mice.

Authors:  Jiamen Shen; Jiatian Dong; Mingsheng Fu; Yuankun Cai; Jiaying Zhao; Tao Ye; Lifeng Gong; Huipeng Wang; Wenjie Chen
Journal:  Ann Transl Med       Date:  2022-03

2.  Enhanced Apoptosis by Functionalized Highly Reduced Graphene Oxide and Gold Nanocomposites in MCF-7 Breast Cancer Cells.

Authors:  Syed Farooq Adil; Mohammed Rafi Shaik; Fahd A Nasr; Ali S Alqahtani; Mohammad Z Ahmed; Wajhul Qamar; Mufsir Kuniyil; Adibah Almutairi; Abdulrahman Alwarthan; Mohammed Rafiq H Siddiqui; Mohammad Rafe Hatshan; Mujeeb Khan
Journal:  ACS Omega       Date:  2021-06-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.